Thymosinα1 is chemopreventive for lung adenoma formation in A/J mice

Cancer Letters

Volumn 155, Issue 2, 2000, Pages 121-127

  Moody, Terry W ^a   Leyton, Julius ^a   Zia, Farah ^a   Tuthill, Cynthia ^b   Badamchian, Mahnaz ^c   Goldstein, Allan L ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SciClone Pharmaceuticals Inc   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

A J mice; Chemoprevention; Lung adenomas; Thymosin 1

Indexed keywords

PROTHYMOSIN ALPHA; THYMOSIN ALPHA1; URETHAN; CARCINOGEN; DRUG DERIVATIVE; THYMOSIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; LEUKOCYTE COUNT; LUNG ADENOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; WESTERN BLOTTING; ADENOMA; ANIMAL; BLOOD; BRONCHUS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LUNG; LUNG ALVEOLUS; LUNG TUMOR; METABOLISM; TIME; TISSUE DISTRIBUTION;

ANIMALIA; BRONCHUS;

ADENOMA; ANIMALS; BLOOD; BLOTTING, WESTERN; BRONCHI; CARCINOGENS; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MICE; PULMONARY ALVEOLI; RADIOIMMUNOASSAY; THYMOSIN; TIME FACTORS; TISSUE DISTRIBUTION; URETHANE;

EID: 0034738174     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00405-5     Document Type: Article

References (38)

1. F. Cuttitta D.N. Carney J. Mulshine T.W. Moody J. Fedorko A. Fischler J.D. Minna Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer Nature 316 1985 823 825
2. T.W. Moody D.N. Carney D. N F. Cuttitta K. Quattrocchi J.D. Minna High affinity receptors for bombesin/GRPlike peptides on human small cell lung cancer Life Sci. 37 1985 105 113
3. Y. Nakanishi J. Mulshine P.F. Kasprzyk R. Natale R. Maneckjee I. Avis A.M. Treston A.F. Gazdar A.F. J D. Minna F. Cuttitta Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro J. Clin. Invest. 82 1989 354 359
4. M.J. Kelly R.I. Linnoila I.L. Avis M.S. Georgiadis F. Cuttitta J.L. Mulshine B.E. Johnson Anti-tumor activity of a monoclonal antibody directed against gastrin releasing peptide in patients with small cell lung cancer Chest 112 1997 256 261
5. J.B. Trepel J.D. Moyer F. Cuttitta H. Frucht D.H. Coy R.B. Natale J.L. Mulshine R.T. Jensen E.A. Sausville A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line Biochem. Biophys. Res. Commun. 156 1988 1383 1389
6. S. Mahmoud J. Staley J. Taylor A. Bogden J.P. Moreau D. Coy I. Avis F. Cuttitta J.L. Mulshine T.W. Moody (Psi-13,14) Bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo Cancer Res. 51 1991 1798 1802
7. F. Zia S. Jacobs F. Kull Jr. F. Cuttitta J.L. Mulshine T.W. Moody Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo J. Cell Biochem. 24S 1996 269 275
8. K. Imanishi K. Yamaguchi M. Kuranami E. Kyo T. Hozumi K. Abe Inhibition of growth of human lung adenocarcinoma cell lines by antitransforming growth factor-a monoclonal antibody J. Natl. Cancer Inst. 81 1989 220 223
9. J.M. Siegfried S.M. Owens Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line Cancer Res. 48 1988 4976 4981
10. T.W. Moody Peptides and growth factors in non-small cell lung cancer Peptides 17 1996 545 555
11. J. Luis S. Said Characterization of VIP and helodermin-preferring receptors on human small cell lung carcinoma cell lines Peptides 11 1990 1239 1244
12. L.Y. Korman D.N. Carney M.L. Citron T.W. Moody Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer Cancer Res. 46 1986 1214 1218
13. T.W. Moody F. Zia M. Draoui D.E. Brenneman M. Fridkin A. Davidson I. Gozes A novel VIP antagonist inhibits non-small cell lung cancer growth Proc. Natl. Acad. Sci. USA 90 1993 4345 4349
14. M. Lee M. Draoui F. Zia A.F. Gazdar H. Oie C. Tarr F. Bellot R. Kris T.W. Moody Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines Monographs 13 1992 117 123
15. S.B. Jakowlew T.W. Moody J.M. Mariano Transforming growth factor β receptors in human cancer cell lines: analysis of transcript, protein and proliferation Anticancer Res. 17 1997 1849 1860
16. A.L. Goldstein T.L.K. Low M. McAdoo J. McClure G.B. Thurman J. Rossio C.Y. Lai D. Chang S.S. Wang C. Harvey A.H. Ramer J. Meienhofer Thymosin α1: Isolation and sequence analysis of an immunologically active thymic polypeptide Proc. Natl. Acad. Sci. USA 74 1979 725729
17. M. Grangou-Laxaridis M. Clinton G.J. Goodall B.L. Horecker Prothymosin α and parathymosin: Amino acid sequences deduced from the cloned rat spleen cDNAs Arch. Biochem. Biophys. 263 1988 305 310
18. M.H. Cohen P.B. Chretien D.C. Ihde B.E. Fossieck R. Makuch P.A. Bunn A.V. Johnston S.E. Shackney M.J. Matthews S.D. Lipson D.E. Kenady J.D. Minna Thymosin fraction 5 and intensive combination chemotherapy prolonging the survival of patients with small-cell lung cancer J. Am. Med. Assoc. 241 1979 1813 1821
19. R.S. Schulof M.J. Lloyd P.A. Cleary S.R. Palaszynski D.A. Mai J.W. Cox O. Alabaster A. Goldstein A randomised trial to evaluate the immunorestorative properties of synthetic thymosin α1 in patients with lung cancer J. Biological Response Modifiers 4 1985 147 158
20. E. Garaci A. Mastino F. Pica C. Favilli Combination treatment using thymosin α1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice Cancer Immunol. Immunother. 32 1990 154 160
21. F. Salvati G. Rasi L. Portalone A. Antilli E. Garaci Combined treatment with thymosin α1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: A phase-II controlled trial Anticancer Res. 16 1996 1001 1004
22. T.W. Moody M. Fagarasan F. Zia M. Cesnjaj A.L. Goldstein Thymosin alpha 1 down regulates the growth of human non-small cell lung cancer Cancer Res. 53 1993 5214 5218
23. A.M. Malkinson Primary lung tumors in mice: An experimentally manipulable model of human adenocarcinoma Cancer Res. 52S 1992 2670 2676
24. M. Ebina S.M. Steinberg J.L. Mulshine R.I. Linnoila Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer Cancer Res. 54 1994 2496 2503
25. O.H. Lowry N.J. Rosebrough A.L. Farr R. Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1957 265 275
26. T. Moody M. Fagarasan M. Gozes Inhibition of non-small cell lung cancer growth by thymosin α1 analogues H.R. Mauer A.L. Goldstein E.D. Hager Thymic Peptides in Preclinical and Clinical Medicine 1996 W. Zuckschwerdt Verlag Munchen 77 88
27. T.W. Moody J. Leyton A. Malkinson S. Hong I. Avis J.L. Mulshine Lipoxygenase inhibitors as lung cancer chemopreventive agents Exp. Lung Res. 24 1998 617 628
28. C. Duperron A. Castonguay Chemoprevention efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice Carcinogenesis 18 1997 1001 1006
29. J.W. Allen G.D. Stoner M.A. Pereira L.C. Backler Tumorigenesis and genotoxicity of ethyl carbamate and vinyl carbamate in rodent cells Cancer Res. 46 1986 4911 4915
30. M. You U. Candrian R.R. Maronpot G.D. Stoner M.W. Anderson Activation of the k-ras protooncogene in spontaneously occuring and chemically induced lung tumors of the strain A mouse Proc. Natl. Acad. Sci. USA 86 1989 3070 3074
31. A. Castonguay D. Lin G.D. Stoner P. Radok S.S. Furaya S.S. Hecht A.G. Schut J.E. Klauning Comparative carcinogenecity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues Cancer Res. 43 1993 1223 1229
32. B. Chen L. Johanson J.S. Wiest M.W. Anderson M. You The second intron of K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility Proc. Natl. Acad. Sci. USA 91 1994 1589 1593
33. S.B. Jakowlew T.W. Moody T.W.L. You J.M. Mariano Reduction in transforming growth factor-β type II receptor in mouse lung carcinogenesis Mol. Carcinogenesis 22 1998 46 56
34. J.R. Calvo J.M. Guerrero R. Goberna Interactions of thymic peptide thymosin α1 with VIP receptors in rat intestinal epithelial cells: Comparison with PHI and secretin Gen. Pharmacol. 20 1989 503 505
35. T.W. Moody F. Zia A. Goldstein P. Naylor E. Sarin D. Brenneman A.M.C. Koros J.C. Reubi M. Fridkin I. Gozes VIP analogues inhibit small cell lung cancer growth Biomed. Res. 13 1993 131 136
36. N. Alvarez L.J. Cordero Prothymosin α1: Studies on its mode of action on immune cells H.R. Mauer A.L. Goldstein E.D. Hager Thymic Peptides in Preclinical and Clinical Medicine 1996 W. Zuckschwerdt Verlag Munchen 28 40
37. M. Clinton M. Frangou-Lazaridis C. Panneerselvam B.L. Horecker Prothymosin α and parathymosin: mRNA and polypeptide levels in rodent tissues Arch. Biochem. Biophys. 269 1988 256 263
38. M. Mervic T.W. Moody A. Komoriya structure function study of bombesin's C-terminal domain Peptides 12 1991 1149 1151